Ketamine is classified for a Schedule III controlled substance under the Controlled Substance Act and, as observed above, approved through the FDA for anesthetic indications [73]. Common adverse effects involved with anesthetic ketamine use contain emergence reactions, hemodynamic instability, and respiratory depression. These signs and symptoms are really almost never https://edwinh900qhv9.wikicommunications.com/user